{"title":"父亲丙戊酸治疗的纠正与儿童神经发育障碍的风险gary, J, Damkier, P., Scialli, A., Lusskin, S., Braddock, S., Chouchana, L., Cleary, B., Conover, E., diavi - citrin, O., Dragovich, R., Garcia-Bournissen, F., Hodson, K., Kennedy, D., Lamm, S., Lavigne, S., obi<e:1> an, S., Panchaud, A., Perrotta, K., Romeo, A., Shechtman, S.和Weber-Schoendorfer, C.(2024),父亲丙丙酸钠治疗和儿童神经发育障碍的风险:预防性监管措施的依据不足。出生缺陷研究,16(6):391 - 391。https://doi.org/10.1002/bdr2.2392。","authors":"","doi":"10.1002/bdr2.2430","DOIUrl":null,"url":null,"abstract":"<p>\n <span>Garey, J.</span>, <span>Damkier, P.</span>, <span>Scialli, A.</span>, <span>Lusskin, S.</span>, <span>Braddock, S.</span>, <span>Chouchana, L.</span>, <span>Cleary, B.</span>, <span>Conover, E.</span>, <span>Diav-Citrin, O.</span>, <span>Dragovich, R.</span>, <span>Garcia-Bournissen, F.</span>, <span>Hodson, K.</span>, <span>Kennedy, D.</span>, <span>Lamm, S.</span>, <span>Lavigne, S.</span>, <span>Običan, S.</span>, <span>Panchaud, A.</span>, <span>Perrotta, K.</span>, <span>Romeo, A.</span>, <span>Shechtman, S.</span> and <span>Weber-Schoendorfer, C.</span> (<span>2024</span>), <span>Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated</span>. <i>Birth Defects Research</i>, <span>116</span>: e2392. https://doi.org/10.1002/bdr2.2392\n </p><p>In the originally published article, the affiliations for Shari Lusskin, Stephen R. Braddock, Laurent Chouchana, and Brian Cleary were given incorrectly. The correct authors and affiliations are given below:</p><p>Joan D. Garey<sup>1</sup>, Per Damkier<sup>2,3</sup>, Anthony R. Scialli<sup>1</sup>, Shari Lusskin<sup>4</sup>, Stephen R. Braddock<sup>5</sup>, Laurent Chouchana<sup>6</sup>, Brian Cleary<sup>7,8</sup>, | Elizabeth A. Conover<sup>9</sup>, Orna Diav-Citrin<sup>10,11</sup>, Rachel S. Dragovich<sup>12</sup>, Facundo Garcia-Bournissen<sup>13</sup>, Ken Hodson<sup>14</sup>, Debra Kennedy<sup>15</sup>, Steven H. Lamm<sup>16</sup>, Sharon A. Lavigne<sup>17</sup>, Sarah G. Običan<sup>18</sup>, Alice Panchaud<sup>19,20</sup>, Kirstie Perrotta<sup>21</sup>, Alfred N. Romeo<sup>22</sup>, Svetlana Shechtman<sup>10</sup>, Corinna Weber-Schoendorfer<sup>23</sup>.</p><p><sup>1</sup>Reproductive Toxicology Center, A Non-Profit Foundation, Washington, DC, USA.</p><p><sup>2</sup>Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</p><p><sup>3</sup>Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.</p><p><sup>4</sup>Departments of Psychiatry and Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</p><p><sup>5</sup>Division of Medical Genetics, Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri, USA.</p><p><sup>6</sup>Regional Center of Pharmacovigilance, Department of Pharmacology, Cochin Port Royal Hospital, APHP, Paris, France.</p><p><sup>7</sup>The Rotunda Hospital, Dublin, Ireland.</p><p><sup>8</sup>School of Pharmacy and Biomedical Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</p><p><sup>9</sup>Division of Clinical Genetics, Munroe Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.</p><p><sup>10</sup>The Israeli Teratology Information Service, Ministry of Health, Jerusalem, Israel.</p><p><sup>11</sup>The Hebrew University Hadassah Medical School, Jerusalem, Israel.</p><p><sup>12</sup>Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, Ohio, USA.</p><p><sup>13</sup>Department of Pediatrics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.</p><p><sup>14</sup>UK Teratology Information Service, Newcastle upon Tyne, UK.</p><p><sup>15</sup>Royal Hospital for Women, Randwick, New South Wales, Australia.</p><p><sup>16</sup>Center for Epidemiology and Maternal-Child Health (CEOH), Washington, DC, USA.</p><p><sup>17</sup>MotherToBaby Connecticut, Division of Medical Genetics, UConn Health, Farmington, Connecticut, USA.</p><p><sup>18</sup>Department of Obstetrics and Gynecology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.</p><p><sup>19</sup>Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.</p><p><sup>20</sup>Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</p><p><sup>21</sup>Department of Pediatrics, University of California, San Diego, La Jolla, California, USA.</p><p><sup>22</sup>MotherToBaby Utah, Utah Department of Health, Salt Lake City, Utah, USA.</p><p><sup>23</sup>Charité—Universitätsmedizin Berlin, Pharmakovigilanzzentrum Embryonaltoxikologie, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany.</p><p>The online version of the article has been corrected.</p><p>We apologize for this error.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"117 1","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bdr2.2430","citationCount":"0","resultStr":"{\"title\":\"Correction to Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated Garey, J., Damkier, P., Scialli, A., Lusskin, S., Braddock, S., Chouchana, L., Cleary, B., Conover, E., Diav-Citrin, O., Dragovich, R., Garcia-Bournissen, F., Hodson, K., Kennedy, D., Lamm, S., Lavigne, S., Običan, S., Panchaud, A., Perrotta, K., Romeo, A., Shechtman, S. and Weber-Schoendorfer, C. (2024), Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated. Birth Defects Research, 116: e2392. https://doi.org/10.1002/bdr2.2392\",\"authors\":\"\",\"doi\":\"10.1002/bdr2.2430\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>\\n <span>Garey, J.</span>, <span>Damkier, P.</span>, <span>Scialli, A.</span>, <span>Lusskin, S.</span>, <span>Braddock, S.</span>, <span>Chouchana, L.</span>, <span>Cleary, B.</span>, <span>Conover, E.</span>, <span>Diav-Citrin, O.</span>, <span>Dragovich, R.</span>, <span>Garcia-Bournissen, F.</span>, <span>Hodson, K.</span>, <span>Kennedy, D.</span>, <span>Lamm, S.</span>, <span>Lavigne, S.</span>, <span>Običan, S.</span>, <span>Panchaud, A.</span>, <span>Perrotta, K.</span>, <span>Romeo, A.</span>, <span>Shechtman, S.</span> and <span>Weber-Schoendorfer, C.</span> (<span>2024</span>), <span>Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated</span>. <i>Birth Defects Research</i>, <span>116</span>: e2392. https://doi.org/10.1002/bdr2.2392\\n </p><p>In the originally published article, the affiliations for Shari Lusskin, Stephen R. Braddock, Laurent Chouchana, and Brian Cleary were given incorrectly. The correct authors and affiliations are given below:</p><p>Joan D. Garey<sup>1</sup>, Per Damkier<sup>2,3</sup>, Anthony R. Scialli<sup>1</sup>, Shari Lusskin<sup>4</sup>, Stephen R. Braddock<sup>5</sup>, Laurent Chouchana<sup>6</sup>, Brian Cleary<sup>7,8</sup>, | Elizabeth A. Conover<sup>9</sup>, Orna Diav-Citrin<sup>10,11</sup>, Rachel S. Dragovich<sup>12</sup>, Facundo Garcia-Bournissen<sup>13</sup>, Ken Hodson<sup>14</sup>, Debra Kennedy<sup>15</sup>, Steven H. Lamm<sup>16</sup>, Sharon A. Lavigne<sup>17</sup>, Sarah G. Običan<sup>18</sup>, Alice Panchaud<sup>19,20</sup>, Kirstie Perrotta<sup>21</sup>, Alfred N. Romeo<sup>22</sup>, Svetlana Shechtman<sup>10</sup>, Corinna Weber-Schoendorfer<sup>23</sup>.</p><p><sup>1</sup>Reproductive Toxicology Center, A Non-Profit Foundation, Washington, DC, USA.</p><p><sup>2</sup>Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</p><p><sup>3</sup>Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.</p><p><sup>4</sup>Departments of Psychiatry and Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</p><p><sup>5</sup>Division of Medical Genetics, Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri, USA.</p><p><sup>6</sup>Regional Center of Pharmacovigilance, Department of Pharmacology, Cochin Port Royal Hospital, APHP, Paris, France.</p><p><sup>7</sup>The Rotunda Hospital, Dublin, Ireland.</p><p><sup>8</sup>School of Pharmacy and Biomedical Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</p><p><sup>9</sup>Division of Clinical Genetics, Munroe Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.</p><p><sup>10</sup>The Israeli Teratology Information Service, Ministry of Health, Jerusalem, Israel.</p><p><sup>11</sup>The Hebrew University Hadassah Medical School, Jerusalem, Israel.</p><p><sup>12</sup>Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, Ohio, USA.</p><p><sup>13</sup>Department of Pediatrics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.</p><p><sup>14</sup>UK Teratology Information Service, Newcastle upon Tyne, UK.</p><p><sup>15</sup>Royal Hospital for Women, Randwick, New South Wales, Australia.</p><p><sup>16</sup>Center for Epidemiology and Maternal-Child Health (CEOH), Washington, DC, USA.</p><p><sup>17</sup>MotherToBaby Connecticut, Division of Medical Genetics, UConn Health, Farmington, Connecticut, USA.</p><p><sup>18</sup>Department of Obstetrics and Gynecology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.</p><p><sup>19</sup>Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.</p><p><sup>20</sup>Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</p><p><sup>21</sup>Department of Pediatrics, University of California, San Diego, La Jolla, California, USA.</p><p><sup>22</sup>MotherToBaby Utah, Utah Department of Health, Salt Lake City, Utah, USA.</p><p><sup>23</sup>Charité—Universitätsmedizin Berlin, Pharmakovigilanzzentrum Embryonaltoxikologie, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany.</p><p>The online version of the article has been corrected.</p><p>We apologize for this error.</p>\",\"PeriodicalId\":9121,\"journal\":{\"name\":\"Birth Defects Research\",\"volume\":\"117 1\",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-01-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bdr2.2430\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Birth Defects Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/bdr2.2430\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"DEVELOPMENTAL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Birth Defects Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bdr2.2430","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DEVELOPMENTAL BIOLOGY","Score":null,"Total":0}
Correction to Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated Garey, J., Damkier, P., Scialli, A., Lusskin, S., Braddock, S., Chouchana, L., Cleary, B., Conover, E., Diav-Citrin, O., Dragovich, R., Garcia-Bournissen, F., Hodson, K., Kennedy, D., Lamm, S., Lavigne, S., Običan, S., Panchaud, A., Perrotta, K., Romeo, A., Shechtman, S. and Weber-Schoendorfer, C. (2024), Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated. Birth Defects Research, 116: e2392. https://doi.org/10.1002/bdr2.2392
Garey, J., Damkier, P., Scialli, A., Lusskin, S., Braddock, S., Chouchana, L., Cleary, B., Conover, E., Diav-Citrin, O., Dragovich, R., Garcia-Bournissen, F., Hodson, K., Kennedy, D., Lamm, S., Lavigne, S., Običan, S., Panchaud, A., Perrotta, K., Romeo, A., Shechtman, S. and Weber-Schoendorfer, C. (2024), Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated. Birth Defects Research, 116: e2392. https://doi.org/10.1002/bdr2.2392
In the originally published article, the affiliations for Shari Lusskin, Stephen R. Braddock, Laurent Chouchana, and Brian Cleary were given incorrectly. The correct authors and affiliations are given below:
Joan D. Garey1, Per Damkier2,3, Anthony R. Scialli1, Shari Lusskin4, Stephen R. Braddock5, Laurent Chouchana6, Brian Cleary7,8, | Elizabeth A. Conover9, Orna Diav-Citrin10,11, Rachel S. Dragovich12, Facundo Garcia-Bournissen13, Ken Hodson14, Debra Kennedy15, Steven H. Lamm16, Sharon A. Lavigne17, Sarah G. Običan18, Alice Panchaud19,20, Kirstie Perrotta21, Alfred N. Romeo22, Svetlana Shechtman10, Corinna Weber-Schoendorfer23.
1Reproductive Toxicology Center, A Non-Profit Foundation, Washington, DC, USA.
2Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
3Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.
4Departments of Psychiatry and Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
5Division of Medical Genetics, Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
6Regional Center of Pharmacovigilance, Department of Pharmacology, Cochin Port Royal Hospital, APHP, Paris, France.
7The Rotunda Hospital, Dublin, Ireland.
8School of Pharmacy and Biomedical Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
9Division of Clinical Genetics, Munroe Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.
10The Israeli Teratology Information Service, Ministry of Health, Jerusalem, Israel.
11The Hebrew University Hadassah Medical School, Jerusalem, Israel.
12Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, Ohio, USA.
13Department of Pediatrics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
14UK Teratology Information Service, Newcastle upon Tyne, UK.
15Royal Hospital for Women, Randwick, New South Wales, Australia.
16Center for Epidemiology and Maternal-Child Health (CEOH), Washington, DC, USA.
17MotherToBaby Connecticut, Division of Medical Genetics, UConn Health, Farmington, Connecticut, USA.
18Department of Obstetrics and Gynecology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
19Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
20Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
21Department of Pediatrics, University of California, San Diego, La Jolla, California, USA.
22MotherToBaby Utah, Utah Department of Health, Salt Lake City, Utah, USA.
23Charité—Universitätsmedizin Berlin, Pharmakovigilanzzentrum Embryonaltoxikologie, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany.
The online version of the article has been corrected.
期刊介绍:
The journal Birth Defects Research publishes original research and reviews in areas related to the etiology of adverse developmental and reproductive outcome. In particular the journal is devoted to the publication of original scientific research that contributes to the understanding of the biology of embryonic development and the prenatal causative factors and mechanisms leading to adverse pregnancy outcomes, namely structural and functional birth defects, pregnancy loss, postnatal functional defects in the human population, and to the identification of prenatal factors and biological mechanisms that reduce these risks.
Adverse reproductive and developmental outcomes may have genetic, environmental, nutritional or epigenetic causes. Accordingly, the journal Birth Defects Research takes an integrated, multidisciplinary approach in its organization and publication strategy. The journal Birth Defects Research contains separate sections for clinical and molecular teratology, developmental and reproductive toxicology, and reviews in developmental biology to acknowledge and accommodate the integrative nature of research in this field. Each section has a dedicated editor who is a leader in his/her field and who has full editorial authority in his/her area.